Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Reiter, A

Class:Id	Person:1602256
_displayName	Reiter, A
_timestamp	2011-09-13 15:02:17
created	[InstanceEdit:1602255] Rothfels, K, 2011-09-13
firstname	Andreas
initial	A
surname	Reiter
(author)	[LiteratureReference:1602276] Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome [LiteratureReference:1604434] The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins [LiteratureReference:1606447] The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1 [LiteratureReference:9673849] Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia [LiteratureReference:9703236] Myeloid neoplasms with eosinophilia [LiteratureReference:9703277] Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3 [LiteratureReference:9706590] Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms [LiteratureReference:9706664] Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism
[Change default viewing format]

No pathways have been reviewed or authored by Reiter, A (1602256)